Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

15.45

-0.40 (-2.52%)

At close: Aug 10, 2026, 4:00 PM EDT

15.50

+0.05 (0.32%)

After-hours: Aug 10, 2026, 6:35 PM EDT

Aurinia Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	286.86	283.06	235.13	175.51	134.03	45.61
Revenue Growth	18.75%	20.38%	33.97%	30.95%	193.89%	-9.01%
Gross Profit	258.77	250.39	206.89	161.37	128.37	44.51
Operating Income	137.02	104.91	-4.69	-91.69	-111.47	-180.74
Net Income	303.03	287.2	5.75	-78.02	-108.18	-180.97
Earnings Per Share	2.29	2.07	0.04	-0.54	-0.76	-1.40
EPS Growth	432.56%	5075.00%	-	-	-	-

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	263.84	210.1	157.96	102.46	45.49
Japan	19.21	25.04	17.56	31.48	-
Total	283.06	235.13	175.51	134.03	45.61

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	311.89	398	358.48	350.49	389.39	466.08
Total Debt	45.14	74.81	79.37	97.61	8.09	8.74
Net Cash (Debt)	266.74	323.19	279.11	252.88	381.3	457.34
Net Cash Growth	14.33%	15.79%	10.37%	-33.68%	-16.63%	17.29%
Net Cash Per Share	1.95	2.33	1.91	1.77	2.69	3.54

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	150.03	135.66	44.39	-33.46	-79.53	-157.69
Capital Expenditures	-0.16	-0.25	-0.28	-0.72	-0.29	-0.3
Free Cash Flow	149.87	135.41	44.11	-34.18	-79.82	-158
Free Cash Flow Growth	62.14%	206.99%	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.21%	88.46%	87.99%	91.94%	95.77%	97.61%
Operating Margin	47.77%	37.06%	-1.99%	-52.24%	-83.17%	-396.31%
Pretax Margin	50.87%	40.33%	3.17%	-44.14%	-79.35%	-395.15%
Profit Margin	105.64%	101.47%	2.45%	-44.45%	-80.71%	-396.81%
FCF Margin	52.24%	47.84%	18.76%	-19.47%	-59.55%	-346.44%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	6.71	7.71	224.50	-	-	-
Forward PE	19.81	19.69	24.06	-	-	-
P/FCF Ratio	11.76	15.59	28.68	-	-	-
PS Ratio	6.61	7.46	5.38	7.37	4.59	71.01